Search Results - "Ruby, Alan J"

Vancomycin-Associated Hemorrhagic Occlusive Retinal Vasculitis: A Clinical-Pathophysiological Analysis by Todorich, Bozho, Faia, Lisa J., Thanos, Aristomenis, Amin, Mitual, Folberg, Robert, Wolfe, Jeremy D., Todorich, Krista M., Raphtis, Efthemios, Ruby, Alan J., Williams, George A., Hassan, Tarek S.

“…To derive novel insights into the pathophysiology of vancomycin-related hemorrhagic occlusive retinal vasculopathy (HORV) through a careful clinicopathologic…”
Get full text

Vitrectomy for a Symptomatic Lamellar Macular Hole by Garretson, Bruce R., MD, Pollack, John S., MD, Ruby, Alan J., MD, Drenser, Kimberly A., MD, PhD, Williams, George A., MD, Sarrafizadeh, Ramin, MD, PhD

“…Purpose To investigate the surgical findings and outcomes after vitrectomy for a lamellar macular hole (LMH). Design Retrospective, consecutive, interventional…”
Get full text

Short-term efficacy of intravitreal dexamethasone implant in vitrectomized eyes with recalcitrant diabetic macular edema and prior anti-VEGF therapy by Shah, Ankoor, Xi, Mengqiao, Abbey, Ashkan, Yonekawa, Yoshihiro, Faia, Lisa, Hassan, Tarek, Ruby, Alan, Wolfe, Jeremy

“…Purpose: To determine the efficacy of an intravitreal dexamethasone implant (IDI) for diabetic macular edema (DME) in vitrectomized eyes. Methods: This…”
Get full text

Private equity in ophthalmology: differences between present versus past by Ruby, Alan J., Williams, George A.

“…Purpose of review The purpose of this review is to examine the differences between the current private equity model in ophthalmology practices and the failed…”
Get full text

The effect of duration of macular detachment on results after the scleral buckle repair of primary, macula-off retinal detachments by Hassan, Tarek S, Sarrafizadeh, Ramin, Ruby, Alan J, Garretson, Bruce R, Kuczynski, Barbara, Williams, George A

“…To present a current series that determined the effect of duration of macular detachment (DMD) and patient age on postscleral buckle (SB) visual acuity (VA)…”
Get more information

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 by Chew, Emily Y, Clemons, Traci E, Sangiovanni, John Paul, Danis, Ronald P, Ferris, 3rd, Frederick L, Elman, Michael J, Antoszyk, Andrew N, Ruby, Alan J, Orth, David, Bressler, Susan B, Fish, Gary E, Hubbard, George Baker, Klein, Michael L, Chandra, Suresh R, Blodi, Barbara A, Domalpally, Amitha, Friberg, Thomas, Wong, Wai T, Rosenfeld, Philip J, Agrón, Elvira, Toth, Cynthia A, Bernstein, Paul S, Sperduto, Robert D

“…The Age-Related Eye Disease Study (AREDS) formulation for the treatment of age-related macular degeneration (AMD) contains vitamin C, vitamin E, beta carotene,…”
Get more information

Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks by Shaikh, Saad, Ruby, Alan J, Williams, George A

“…To evaluate the efficacy of photodynamic therapy with verteporfin in the management of choroidal neovascularization (CNV) associated with angioid streaks…”
Get full text

FEATURES AND OUTCOMES OF EYES THAT UNDERWENT SURGICAL REPAIR OF RHEGMATOGENOUS RETINAL DETACHMENTS AFTER BEING TREATED FOR ACUTE ENDOPHTHALMITIS by Dong, Libing K., Shields, Ryan A., Subramanian, Sam, Lee, Ramon, Wa, Christianne A., Ruby, Alan J., Hassan, Tarek S.

“…To evaluate the etiology, clinical course, and outcomes of eyes that suffered postendophthalmitis rhegmatogenous retinal detachments. A retrospective,…”
Get full text

RESOLUTION OF SUBRETINAL FLUID AND OUTER RETINAL CHANGES IN PATIENTS TREATED WITH OCRIPLASMIN by Nudleman, Eric, Franklin, Michael S, Wolfe, Jeremy D, Williams, George A, Ruby, Alan J

“…To evaluate the aftermarket efficacy of ocriplasmin for vitreomacular adhesion (VMA) and identify the frequency and duration of structural changes on optical…”
Get full text

Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4 by Chew, Emily Y, SanGiovanni, John Paul, Ferris, Frederick L, Wong, Wai T, Agron, Elvira, Clemons, Traci E, Sperduto, Robert, Danis, Ronald, Chandra, Suresh R, Blodi, Barbara A, Domalpally, Amitha, Elman, Michael J, Antoszyk, Andrew N, Ruby, Alan J, Orth, David, Bressler, Susan B, Fish, Gary E, Hubbard, George B, Klein, Michael L, Friberg, Thomas R, Rosenfeld, Philip J, Toth, Cynthia A, Bernstein, Paul

“…Age-related cataract is a leading cause of visual impairment in the United States. The prevalence of age-related cataract is increasing, with an estimated 30.1…”
Get more information

Incidence and Visual Outcomes of Culture-Proven Endophthalmitis Following Dexamethasone Intravitreal Implant by Stem, Maxwell S, Todorich, Bozho, Yonekawa, Yoshihiro, Capone, Jr, Antonio, Williams, George A, Ruby, Alan J

“…The rate of endophthalmitis following dexamethasone intravitreal implant (DEX) has varied in large clinical trials. Furthermore, to our knowledge, the optimal…”
Get more information

LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION by Begaj, Tedi, Jeong, Daeun, Park, Jong G, Runner, Margaret M, Capone, Jr, Antonio, Dass, A Bawa, Drenser, Kimberly A, Faia, Lisa J, Farley, Nathan D, Garretson, Bruce R, Hassan, Tarek S, Mahmoud, Tamer H, Margherio, Alan, Raphaelian, Paul V, Randhawa, Sandeep, Ruby, Alan J, Sneed, Scott, Rao, Prethy, Wolfe, Jeremy D, Williams, George A

“…Although pivotal trials have demonstrated efficacy of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration, there is…”
Get full text

LONG-TERM VISUAL OUTCOMES AND THE TIMING OF SURGICAL REPAIR OF FOVEA-SPLITTING RHEGMATOGENOUS RETINAL DETACHMENTS by Lee, Ramon, Shields, Ryan A., Maywood, Michael J., Nemeth, Cire, Wa, Christianne A., Williams, George A., Hassan, Tarek S., Garretson, Bruce R., Capone, Antonio, Ruby, Alan J., Drenser, Kimberly A., Faia, Lisa J., Randhawa, Sandeep, Mahmoud, Tamer H., Wolfe, Jeremy D.

“…To evaluate the visual outcomes and the affect of timing of surgical repair of fovea-splitting rhegmatogenous retinal detachments. A retrospective, consecutive…”
Get full text

Surgical Management of Full-Thickness Macular Holes in Macular Telangiectasia Type 2: A Global Multicenter Study by Park, Jong G, Adrean, Sean D, Begaj, Tedi, Capone, Jr, Antonio, Charles, Steve, Chen, San-Ni, Chou, Hung-Da, Cohen, Michael N, Corona, Stephanie Trejo, Faia, Lisa J, Garg, Sunir J, Garretson, Bruce R, Gregori, Ninel Z, Haller, Julia A, Houghton, Odette Margit, Hsu, Jason, Jo, Jaehyuck, Kaiser, Richard S, Lai, Chi-Chun, Mahgoub, Mohamed Moghazy, Mansoor, Mahsaw, Matoba, Ryo, Morizane, Yuki, Nehemy, Marcio B, Raphaelian, Paul V, Regillo, Carl D, Ruby, Alan J, Runner, Margaret M, Sneed, Scott R, Sohn, Elliott H, Spirn, Marc J, Vander, James F, Wakabayashi, Taku, Wolfe, Jeremy D, Wykoff, Charles C, Yonekawa, Yoshihiro, Yoon, Young Hee, Mahmoud, Tamer H

“…To report on macular hole repair in macular telangiectasia type 2 (MacTel2). Global, multicenter, retrospective case series. Patients undergoing surgery for…”
Get full text

Retinal Complications after Yttrium-Aluminum-Garnet Laser Vitreolysis for Vitreous Floaters by Shields, Ryan A, Cheng, Olivia T, Ruby, Alan J, Williams, George A, Wolfe, Jeremy D

“…This is an observational case series of two patients who developed direct retinal damage following neodymium-doped yttrium-aluminum-garnet (YAG) laser…”
Get more information

DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR by Thanos, Aristomenis, Todorich, Bozho, Yonekawa, Yoshihiro, Papakostas, Thanos D, Khundkar, Tahsin, Eliott, Dean, Dass, Ashvani B, Williams, George A, Capone, Jr, Antonio, Faia, Lisa J, Wolfe, Jeremy D, Hassan, Tarek S, Ruby, Alan J

“…To investigate the efficacy of the intravitreal dexamethasone implant as the treatment for recalcitrant macular edema after successful rhegmatogenous retinal…”
Get full text

PERIPHERAL RETINAL ANGIOGRAPHIC FINDINGS IN MACULAR TELANGIECTASIS TYPE 2 by Moysidis, Stavros N, Koulisis, Nicole, Rao, Prethy, Govindaraju, Viren K, Gamsky, Samuel, Mahmoud, Tamer H, Randhawa, Sandeep, Faia, Lisa J, Wolfe, Jeremy D, Drenser, Kimberly A, Ruby, Alan J, Garretson, Bruce R, Hassan, Tarek S, Williams, George A, Trese, Michael T, Capone, Jr, Antonio

“…To evaluate the retinal periphery in patients with idiopathic juxtafoveal telangiectasis or macular telangiectasis Type 2 (MacTel2), using widefield…”
Get full text

CLINICAL OUTCOMES AND TREATMENT COURSE OF EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION FOLLOWING THE DEVELOPMENT OF ENDOPHTHALMITIS by Koulisis, Nicole, Moysidis, Stavros N., Govindaraju, Viren K., Dersch, Anne Merrylees, Capone, Antonio, Covert, Douglas J., Dadgostar, Hajir, Dass, A. Bawa, Drenser, Kimberly A., Engstrom, Robert E., Faia, Lisa J., Garretson, Bruce R., Guerami, Amir H., Hanscom, Thomas A., Mahmoud, Tamer H., Margherio, Alan R., Oh, Kean T., Randhawa, Sandeep, Raphaelian, Paul V., Rhoades, William R., Ruby, Alan J., Sanfilippo, Christian J., Sneed, Scott R., Trese, Michael T., Wolfe, Jeremy D., Williams, George A., Yedavally, Sunita, Hassan, Tarek S.

“…To evaluate the clinical course of patients with neovascular age-related macular degeneration (nAMD) after developing endophthalmitis during their treatment…”
Get full text

Self-reported acute decrease in visual acuity after photodynamic therapy for age-related macular degeneration by Recchia, Franco M, Greenbaum, Shareen, Recchia, Cynthia A Carvalho, Ruby, Alan J, Alldredge, Claron D, Hassan, Tarek S

“…To evaluate the incidence of self-reported decrease in visual acuity within 7 days of photodynamic therapy (PDT) for choroidal neovascularization secondary to…”
Get full text

Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength by Stem, Maxwell S, Rao, Prethy, Lee, Ivan J, Woodward, Maria A, Faia, Lisa J, Wolfe, Jeremy D, Capone, Jr, Antonio, Covert, Douglas, Dass, A Bawa, Drenser, Kimberly A, Garretson, Bruce R, Hassan, Tarek S, Margherio, Alan, Oh, Kean T, Raephaelian, Paul V, Randhawa, Sandeep, Sneed, Scott, Trese, Michael T, Yedavally, Sunita, Williams, George A, Ruby, Alan J

“…To determine the incidence of endophthalmitis after anti-vascular endothelial growth factor (VEGF) therapy at our institution and to identify potential risk…”
Get more information